DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Highly effective preservation solutions ensuring the safety and protection of personal care products
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
It is the first autotaxin inhibitor to be investigated in cancer patients
Subscribe To Our Newsletter & Stay Updated
